611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Cancer
Resources
Basic InformationLatest News
Vascular Targeted Photodynamic Tx Aids Low-Risk Prostate CancerObesity in Teen Years Tied to Colon Cancer Risk in AdulthoodASCO Addresses Cancer Drug PricingSenator McCain Faces a Tough Cancer FoeMore Patients OK'd for Cancer Trials Under Obamacare: StudyInsured, But Still Barred From Top-Tier Cancer CentersMany Terminal Cancer Patients Remain in DenialSingle-Dose PCV13 Immunogenic, Safe in Pediatric OncologyDoctors' Group Offers Ideas for Easing Cancer Costs'Nipple-Sparing' Mastectomies Don't Raise Odds of Cancer's Return: StudyNerlynx Approved to Help Prevent Breast Cancer's ReturnLittle Evidence That Vasectomy Raises Prostate Cancer RiskWait-and-Scan Strategy Feasible for Head, Neck ParagangliomaHigher Nodal Yield Tied to Lower Mortality in Oral Cavity CancerChange to Cervical Screening Guidelines Impacted ChlamydiaBlood Test for Early Detection of Pancreatic Cancer Feasible'Observation' Best Option for Most Low-Risk Prostate CancerAre Big Men More Prone to Aggressive Prostate Cancer?Rivaroxaban OK for Stroke Prevention in Cancer PatientsNew Test May Help Spot Pancreatic Cancer EarlyDecisional Regret Doesn't Differ by Treatment in Prostate CancerEasier Colon Exam Boosts Screening, But Insurers May Not PayParkinson's Patients Deemed at Higher Risk of MelanomaMost Breast Cancer Patients Have Help Choosing TreatmentsFor Holocaust Survivors, Raised Risk of CancerParkinson's Disease and Melanoma May Occur Together, Study FindsGermline Mutations Up in Men With Prostate CA, One Other CACancer Deaths Higher in Rural America, CDC ReportsFDA Widens Access to 'Cooling Cap' to Stop Hair Loss in Cancer PatientsNivolumab Rx Beyond Progression Beneficial in MelanomaMany Women Have Questions, Concerns About TamoxifenMelanoma Diagnoses Can Vary Widely Among PathologistsMany Women Mistaken on 'Side Effects' of Breast Cancer DrugMelanoma Biopsy Results Can Differ, Worrying PatientsNew Microscope Scans Breast Tumors During SurgeryCan You Recognize the Signs of Skin Cancer?Reduced Cancer-Independent Life Expectancy in Head, Neck CancerMore Breast Cancers Diagnosed at Late Stage With Medicaid CutsSimilar Skin Cancer Incidence Seen With TeledermatologyMedicaid Cuts Tied to Delayed Breast Cancer DiagnosesACOG: Shared Decision-Making Key to Breast Cancer ScreeningDrug, Herb Interactions Frequent for Cancer PatientsMany With Advanced Cancer Want Secondary Germline Findings InfoSecondhand Smoke Still Plagues Some Cancer SurvivorsBig Gap in Cancer Deaths Between Rich, Poor CountriesMany Doctors Silent on Cost of Cancer CareFamily Hx, Mutation Position Key Variables in BRCA1/2 Cancer RiskWeight-Loss Program Aids Black Breast Cancer SurvivorsWhen Is Risk Highest for Women With Breast Cancer Gene Mutations?Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Wait-and-Scan Strategy Feasible for Head, Neck Paraganglioma


HealthDay News
Updated: Jul 17th 2017

new article illustration

MONDAY, July 17, 2017 (HealthDay News) -- A wait-and-scan strategy seems to be feasible for patients with head and neck paraganglioma (PGL), according to a study published online July 10 in Head & Neck.

Thijs T.G. Jansen, from the Radboud University Medical Center in Nijmegen, Netherlands, and colleagues conducted a retrospective cohort study involving patients with head and neck PGL. The authors measured tumor growth in axial plane diameter and tumor volume during a wait-and-scan period.

The researchers found that 44 percent of 59 jugulotympanic tumors, 71 carotid body tumors, and 29 vagal body tumors were growing (median growth rates, 0.41, 1.6, and 1.6 mm/year, respectively). There was a significant correlation for growth with age at presentation (odds ratio, 0.974; P < 0.05). Twenty complications were induced by 17 tumors; six of these were growing, and the growth rates were higher than in non-complication-inducing tumors (P = 0.016).

"The results of this study illustrate that a wait-and-scan policy is a feasible treatment option in cases for head and neck PGL, as it potentially prevents treatment-induced morbidity in the majority of patients, including those presenting larger tumors," the authors write. "Our results also suggest that radiological follow-up is not an optimal management strategy, because a large group of tumors were found not to grow, although they did elicit complications, in the main, years after the initial diagnosis."

Abstract
Full Text (subscription or payment may be required)